SECURITIES AND EXCHANGE COMMISSION
Washington, DC 20549
___________
FORM 8-K
CURRENT REPORT
Pursuant to Section 13
or 15(d) of the
Securities Exchange Act of 1934
Date of Report (Date of earliest event reported): May 15, 2001
INTEGRA LIFESCIENCES HOLDINGS CORPORATION |
(Exact name of registrant as specified in its charter) |
Delaware |
0-26224 |
51-0317849 |
(State or other jurisdiction | (Commission | (IRS Employer |
of incorporation) | File Number) | Identification No.) |
311-C Enterprise Drive | |
Plainsboro, New Jersey |
08536 |
(Address of principal executive offices) | (Zip Code) |
Registrant's telephone number, | ||
including area code: | (609) 275-0500 |
|
Not
Applicable |
(Former name or former address, if changed since last report) |
Item 5. Other Events
The Company's Annual Meeting of Stockholders was held on May 15, 2001 and in connection therewith, proxies were solicited by management pursuant to Regulation 14A under the Securities Exchange Act of 1934, as amended. An aggregate of 17,642,155 shares of the Company's common stock ("Common Stock"), 100,000 shares of Series B Preferred Stock (which are convertible into 2,617,801 shares of Common Stock), and 54,000 shares of Series C Preferred Stock (which are convertible into 600,000 shares of Common Stock) (collectively, "Shares") were outstanding and entitled to a vote at the meeting. At the meeting the following matters (not including ordinary procedural matters) were submitted to a vote of the holders of Shares, with the results indicated below:
1. Election of directors to serve until the 2002 Annual Meeting. The following persons, all of whom were serving as directors and were management's nominees for election, were elected. There was no solicitation in opposition to such nominees. The tabulation of votes was as follows:
Nominee
|
For
|
Withheld
|
Keith Bradley | 18,100,636 | 405,740 |
Richard E. Caruso | 18,100,636 | 405,740 |
Stuart M. Essig | 16,544,957 | 1,961,419 |
Neil Moszkowski | 18,101,136 | 405,240 |
George W. McKinney, III | 16,537,857 | 1,968,519 |
James M. Sullivan | 18,101,136 | 405,240 |
2. Approval of the Company's 2001 Equity Incentive Plan. The Company's 2001 Equity Incentive Plan was approved. The tabulation of votes was as follows:
For
|
Against
|
Abstentions
|
13,811,174 | 2,392,352 | 22,910 |
3. Ratification and approval of an amendment to the Companys Certificate of Designation, Rights and Preferences of Series B Convertible Preferred Stock, the purpose of which was to ensure that the rights and preferences of the Series B Convertible Preferred Stock would be substantially identical to the rights and preferences of the Series C Convertible Preferred Stock. This amendment was approved. The tabulation of votes was as follows:
For
|
Against
|
Abstentions
|
16,116,674 | 74,884 | 34,878 |
4. Approval of an amendment to the Companys Certificate of Designation, Rights and Preferences of Series B Convertible Preferred Stock, the purpose of which is to make certain changes to clarify the numbering of certain paragraphs and internal references contained therein. This amendment was approved. The tabulation of votes was as follows:
For
|
Against
|
Abstentions
|
16,135,626 | 57,625 | 33,185 |
5. Approval of an amendment to the Companys Certificate of Designation, Rights and Preferences of Series C Convertible Preferred Stock, the purpose of which is to make certain changes to clarify the numbering of certain paragraphs and internal references contained therein. This amendment was approved. The tabulation of votes was as follows:
For
|
Against
|
Abstentions
|
16,135,020 | 58,204 | 33,212 |
6. Ratification of independent auditors. The appointment of PricewaterhouseCoopers LLP as the Company's independent auditors for the current fiscal year was ratified. The tabulation of votes was as follows:
For
|
Against
|
Abstentions
|
18,477,510 | 22,744 | 6,122 |
ITEM 7. Financial Statements and Exhibits.
(c) Exhibits.
Exhibit
Number (Referenced to Item 601 of Regulation S-K) |
Description
of Exhibit
|
(3)(i).1 | Second Amendment to
Certificate of Rights, Designations and Preferences of Series B Convertible Preferred Stock |
(3)(i).2 | First Amendment to
Certificate of Rights, Designations and Preferences of Series C Convertible Preferred Stock |
SIGNATURES
Pursuant to the requirements of the Securities Exchange Act of 1934, the registrant has duly caused this report to be signed on its behalf by the undersigned hereunto duly authorized.
INTEGRA
LIFESCIENCES HOLDINGS CORPORATION |
|
Date: May 25, 2001 | By: /s/ Stuart M. Essig
|
Stuart
M. Essig, President and Chief Executive Officer |
|
INDEX OF EXHIBITS
Exhibit
No.
|
Description
of Exhibit
|
(3)(i).1 | Second Amendment to
Certificate of Rights, Designations and Preferences of Series B Convertible Preferred Stock |
(3)(i).2 | First Amendment to
Certificate of Rights, Designations and Preferences of Series C Convertible Preferred Stock |